Towards a Consensus in Symptomatic Gastroesophageal Reflux DiseaseFASS, Ronnie.The American journal of gastroenterology. 2003, Vol 98, Num 3, issn 0002-9270, 58 p., SUPConference Proceedings

Epidemiology and pathophysiology of symptomatic gastroesophageal reflux diseaseFASS, Ronnie.The American journal of gastroenterology. 2003, Vol 98, Num 3, pp S2-S7, issn 0002-9270, SUPConference Paper

The economic and quality-of-life impact of symptomatic gastroesophageal reflux diseaseOFMAN, Joshua J.The American journal of gastroenterology. 2003, Vol 98, Num 3, pp S8-S14, issn 0002-9270, SUPConference Paper

Diagnosis of symptomatic gastroesophageal reflux diseaseKAHRILAS, Peter J.The American journal of gastroenterology. 2003, Vol 98, Num 3, pp S15-S23, issn 0002-9270, SUPConference Paper

Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux diseaseQUIGLEY, Eamonn M. M.The American journal of gastroenterology. 2003, Vol 98, Num 3, pp S24-S30, issn 0002-9270, SUPConference Paper

Rabeprazole-based therapy in the management of symptomatic gastroesophageal reflux diseaseSLOAN, Sheldon.The American journal of gastroenterology. 2003, Vol 98, Num 3, pp S49-S55, issn 0002-9270, SUPConference Paper

Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux diseaseBARDHAN, Karna Dev.The American journal of gastroenterology. 2003, Vol 98, Num 3, pp S40-S48, issn 0002-9270, SUPConference Paper

Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patientsBYTZER, Peter.The American journal of gastroenterology. 2003, Vol 98, Num 3, pp S31-S39, issn 0002-9270, SUPConference Paper